Regulation of interleukin 10 release by tumor necrosis factor in humans and chimpanzees - PubMed (original) (raw)

Regulation of interleukin 10 release by tumor necrosis factor in humans and chimpanzees

T van der Poll et al. J Exp Med. 1994.

Abstract

Interleukin 10 (IL-10) has been shown to inhibit endotoxin-induced tumor necrosis factor (TNF) production. To assess the role of TNF in the induction of IL-10 in endotoxemia, four healthy men were studied after a bolus intravenous injection of recombinant human TNF (50 micrograms/m2). In addition, 13 healthy chimpanzees were investigated after a bolus intravenous injection of Escherichia coli endotoxin (4 ng/kg), 6 animals received endotoxin only, 4 animals received a simultaneous intravenous injection of a monoclonal anti-TNF antibody, whereas 3 chimpanzees were treated with an anti-TNF F(ab')2 fragment 30 min after the administration of endotoxin. TNF induced a modest rise in IL-10 concentrations peaking after 45 min (47 +/- 32 pg/ml; p < 0.05). IL-10 peaked 2 h after injection of endotoxin (202 +/- 61 pg/ml; p < 0.005). In both anti-TNF-treated groups, the early endotoxin-induced TNF activity was completely neutralized. Simultaneous anti-TNF treatment attenuated endotoxin-induced IL-10 release (73 +/- 13 pg/ml; p < 0.01 versus endotoxin alone), whereas postponed anti-TNF treatment did not significantly affect this response (p = 0.21). These results indicate that TNF, in part, mediates the induction of IL-10 in endotoxemia, resulting in an autoregulatory feedback loop.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Lancet. 1994 Mar 19;343(8899):707-8 - PubMed
    1. Blood. 1994 Jan 15;83(2):446-51 - PubMed
    1. Eur J Immunol. 1994 May;24(5):1167-71 - PubMed
    1. Science. 1986 Oct 24;234(4775):470-4 - PubMed
    1. Lancet. 1987 Feb 14;1(8529):355-7 - PubMed

MeSH terms

Substances

LinkOut - more resources